LUANNE BIANCHI: Open Payments
NPI 1790724797 · ROCHESTER, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,090 in 43 payments from 9 companies in 2025. Trend: 2023 $1,728 · 2024 $629 · 2025 $1,090
Food & beverage: $1,070Education: $20
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 12 | $454 |
| ABBVIE INC. | 18 | $299 |
| Madrigal Pharmaceuticals | 1 | $131 |
| Regeneron Healthcare Solutions, Inc. | 2 | $54 |
| Gilead Sciences, Inc. | 3 | $52 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $35 |
| Phathom Pharmaceuticals, Inc. | 2 | $28 |
| Janssen Pharmaceuticals, Inc | 2 | $20 |
| Organon LLC | 1 | $18 |
Products named: TREMFYA, RINVOQ, REZDIFFRA, MAVYRET, DUPIXENT, SKYRIZI, ENTYVIO, LINZESS.
Industry payments across NY — which companies pay providers there.
